ArticleEuropean journal of nuclear medicine and molecular imaging2014

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.

Jürgen Grünberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.